BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 18679140)

  • 1. Cerebrospinal fluid cleaved-tau protein and 9-hydroxyoctadecadienoic acid concentrations in pediatric patients with hydrocephalus.
    Cengiz P; Zemlan F; Ellenbogen R; Hawkins D; Zimmerman JJ
    Pediatr Crit Care Med; 2008 Sep; 9(5):524-9. PubMed ID: 18679140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased cerebrospinal fluid cleaved tau protein (C-tau) levels suggest axonal damage in pediatric patients with brain tumors.
    Cengiz P; Zemlan F; Eickhoff JC; Ellenbogen R; Zimmerman JJ
    Childs Nerv Syst; 2015 Aug; 31(8):1313-9. PubMed ID: 25899850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased total-Tau levels in cerebrospinal fluid of pediatric hydrocephalus and brain tumor patients.
    de Bont JM; Vanderstichele H; Reddingius RE; Pieters R; van Gool SW
    Eur J Paediatr Neurol; 2008 Jul; 12(4):334-41. PubMed ID: 17951083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early programmable valve malfunctions in pediatric hydrocephalus.
    Mangano FT; Menendez JA; Habrock T; Narayan P; Leonard JR; Park TS; Smyth MD
    J Neurosurg; 2005 Dec; 103(6 Suppl):501-7. PubMed ID: 16383248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Level of tau protein in children treated for acute lymphoblastic leukemia.
    Muszyńska-Rosłan K; Krawczuk-Rybak M; Protas PT; Hołownia A
    Pediatr Neurol; 2006 May; 34(5):367-71. PubMed ID: 16647996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau protein in the cerebrospinal fluid is a marker of brain injury after aortic surgery.
    Shiiya N; Kunihara T; Miyatake T; Matsuzaki K; Yasuda K
    Ann Thorac Surg; 2004 Jun; 77(6):2034-8. PubMed ID: 15172260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum- and CSF-concentrations of brain specific proteins in hydrocephalus.
    Beems T; Simons KS; Van Geel WJ; De Reus HP; Vos PE; Verbeek MM
    Acta Neurochir (Wien); 2003 Jan; 145(1):37-43. PubMed ID: 12545260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus.
    Agren-Wilsson A; Lekman A; Sjöberg W; Rosengren L; Blennow K; Bergenheim AT; Malm J
    Acta Neurol Scand; 2007 Nov; 116(5):333-9. PubMed ID: 17922727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau protein, phosphorylated tau protein and beta-amyloid42 in the cerebrospinal fluid of multiple sclerosis patients.
    Valis M; Talab R; Stourac P; Andrys C; Masopust J
    Neuro Endocrinol Lett; 2008 Dec; 29(6):971-6. PubMed ID: 19112391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated cerebrospinal fluid levels of glutamate in children with bacterial meningitis as a predictor of the development of seizures or other adverse outcomes.
    Ma W; Shang-Feaster G; Okada PJ; Kernie SG
    Pediatr Crit Care Med; 2003 Apr; 4(2):170-5. PubMed ID: 12749647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients.
    Ritz R; Roser F; Morgalla M; Dietz K; Tatagiba M; Will BE
    BMC Infect Dis; 2007 May; 7():38. PubMed ID: 17488498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter study of factors influencing cerebrospinal fluid shunt survival in infants and children.
    Shah SS; Hall M; Slonim AD; Hornig GW; Berry JG; Sharma V
    Neurosurgery; 2008 May; 62(5):1095-102; discussion 1102-3. PubMed ID: 18580807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital hydrocephalus and ventriculoperitoneal shunts: influence of etiology and programmable shunts on revisions.
    Notarianni C; Vannemreddy P; Caldito G; Bollam P; Wylen E; Willis B; Nanda A
    J Neurosurg Pediatr; 2009 Dec; 4(6):547-52. PubMed ID: 19951042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multi-institutional, 5-year analysis of initial and multiple ventricular shunt revisions in children.
    Berry JG; Hall MA; Sharma V; Goumnerova L; Slonim AD; Shah SS
    Neurosurgery; 2008 Feb; 62(2):445-53; discussion 453-4. PubMed ID: 18382323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic-impregnated shunt catheters for the treatment of infantile hydrocephalus.
    Sciubba DM; Noggle JC; Carson BS; Jallo GI
    Pediatr Neurosurg; 2008; 44(2):91-6. PubMed ID: 18230921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury.
    Ost M; Nylén K; Csajbok L; Ohrfelt AO; Tullberg M; Wikkelsö C; Nellgård P; Rosengren L; Blennow K; Nellgård B
    Neurology; 2006 Nov; 67(9):1600-4. PubMed ID: 17101890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
    Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T
    Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Derivation of cerebrospinal fluid: consequences on inner ear biomechanics in adult patients with chronic hydrocephalus].
    Chomicki A; Sakka L; Avan P; Khalil T; Lemaire JJ; Chazal J
    Neurochirurgie; 2007 Aug; 53(4):265-71. PubMed ID: 17559890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of ventriculoperitoneal shunt placement in Grade IV tubercular meningitis with hydrocephalus: a retrospective analysis in 95 patients. Clinical article.
    Srikantha U; Morab JV; Sastry S; Abraham R; Balasubramaniam A; Somanna S; Devi I; Bangalore CA; Pandey P
    J Neurosurg Pediatr; 2009 Aug; 4(2):176-83. PubMed ID: 19645554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distal slit valve and clinically relevant CSF overdrainage in children with hydrocephalus.
    Virella AA; Galarza M; Masterman-Smith M; Lemus R; Lazareff JA
    Childs Nerv Syst; 2002 Feb; 18(1-2):15-8. PubMed ID: 11935238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.